Literature DB >> 6979753

Recloned colonies positive for T-cell-associated antigens derived from mixed hemopoietic colonies (CFU-GEMM)1.

A A Fauser, G W Löhr.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 6979753     DOI: 10.3181/00379727-170-41422

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  9 in total

1.  T cells and probably B cells arise from the malignant clone in chronic myelogenous leukemia.

Authors:  A A Fauser; L Kanz; K J Bross; G W Löhr
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

2.  Hemopoiesis and differentiation.

Authors:  M L Patchen
Journal:  Surv Immunol Res       Date:  1984

3.  Tumor cell colonies in bone marrow cultures from patients with small cell carcinoma of the lung.

Authors:  H A Neumann; G W Löhr; A A Fauser
Journal:  Blut       Date:  1984-04

4.  Myelo-lymphopoietic stem cells in human bone marrow.

Authors:  A A Fauser; G W Löhr
Journal:  Blut       Date:  1982-09

5.  Restoration of nonclonal hematopoiesis in chronic myelogenous leukemia with interferon alpha.

Authors:  G Egert; L Kanz; G W Löhr; A A Fauser
Journal:  Blut       Date:  1990-05

6.  Identification of B cells in multilineage hematopoietic colonies derived from cells of patients with lymphocytic lymphoma.

Authors:  A A Fauser; L Kanz; G W Löhr
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

7.  Suppressor T-cell clones derived from pluripotent stem cells (CFU-GEMM) of a patient with Hodgkin's lymphoma.

Authors:  A A Fauser; K G Bross; L Kanz; G W Löhr
Journal:  Blut       Date:  1982-08

8.  Human megakaryocytic progenitor cells.

Authors:  L Kanz; G W Löhr; A A Fauser
Journal:  Klin Wochenschr       Date:  1987-04-01

9.  Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells.

Authors:  E Platzer; K Welte; J L Gabrilove; L Lu; P Harris; R Mertelsmann; M A Moore
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.